To define the precise relation between Aβ and tau levels in brain tissue, CSF and/or blood and clinical disease remains an important scientific challenge due to the association between TBI and the risk of developing neurodegeneration and AD. The gene discussed is MAPT; the disease is Alzheimer disease.